Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

49 trials with published results (5%)

Research Maturity

473 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.7%

26 terminated out of 946 trials

Success Rate

94.8%

+8.3% vs benchmark

Late-Stage Pipeline

3%

33 trials in Phase 3/4

Results Transparency

10%

49 of 473 completed with results

Key Signals

49 with results95% success26 terminated

Data Visualizations

Phase Distribution

631Total
Not Applicable (550)
Early P 1 (8)
P 1 (14)
P 2 (26)
P 3 (16)
P 4 (17)

Trial Status

Completed473
Unknown160
Recruiting137
Not Yet Recruiting83
Active Not Recruiting41
Terminated26

Trial Success Rate

94.8%

Benchmark: 86.5%

Based on 473 completed trials

Clinical Trials (946)

Showing 20 of 20 trials
NCT07463092Not ApplicableRecruiting

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

NCT07638449Not ApplicableNot Yet Recruiting

Silkworm Pupa Powder Improves Alzheimer's Disease

NCT07632417Not ApplicableNot Yet RecruitingPrimary

A Study on the Effects of Forest Therapy on Sarcopenia

NCT07601321Not ApplicableNot Yet RecruitingPrimary

BCW-Based Resistance Training for Community-Dwelling Sarcopenia Patients

NCT05935800Active Not Recruiting

The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates

NCT07562698Not ApplicableActive Not RecruitingPrimary

Ursolic Acid-Standardized Apple Pomace Supplementation for Muscle Strength and Physical Performance in Older Adults With Mild Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT07634523Phase 4RecruitingPrimary

Branched Chain Amino Acids for Sarcopenia in Patients Undergoing Total Knee Arthroplasty

NCT06898476Not ApplicableRecruiting

Silkworm Pupa Powder Improves Dementia.

NCT03676478Not ApplicableTerminated

Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and Survival

NCT07325760Not ApplicableNot Yet RecruitingPrimary

Effectiveness of a ReMIND Diet Intervention on Sarcopenia, Cognitive Frailty and Nutritional Status in Older Adults

NCT07629063Not ApplicableActive Not Recruiting

Effectiveness of Resistance Exercises Added to Aerobic and Balance Exercises in Parkinson's Disease

NCT07609160Not ApplicableNot Yet Recruiting

Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals

NCT07625202Not ApplicableRecruitingPrimary

Creatine Supplementation During GLP-1a Therapy

NCT07319377Not ApplicableRecruitingPrimary

Evaluation of Safety and Efficacy of a Digital Therapeutic Device to Improve Strength in Sarcopenia (Sarc-DTx)

NCT04255745Not ApplicableCompletedPrimary

The Impact of a Resistance Training Intervention on Blood Pressure Control in Older Adults With Sarcopenia

NCT01484821Not ApplicableCompletedPrimary

Assessment of in Vivo Skeletal Muscle Viscoelasticity (ARFI Imaging) With Aging and Cancer

NCT07620938Phase 2Not Yet RecruitingPrimary

Clinical Study of TJ0113 Capsule in the Treatment of Patients With Sarcopenia

NCT07075133Not ApplicableNot Yet Recruiting

Chrono-restricted Diet and Physical Activity as a New Preventive Strategy for Sarcopenia in Postmenopausal Women With Obesity and Type 2 Diabetes

NCT07611097Not ApplicableNot Yet Recruiting

Osteoporosis and Sarcopenia Prevention in Middle-Aged Population

NCT07385534Not ApplicableActive Not RecruitingPrimary

Effects of Lower Body EMS Training in Postmenopausal Women

Scroll to load more

Research Network

Activity Timeline